https://www.targetedonc.com/view/fda-approves-belzutifan-for-adult-patients-with-advanced-rcc
FDA Approves Belzutifan for Adult Patients With Advanced RCC | Targeted Oncology - Immunotherapy,...
Oct 16, 2026 - Belzutifan is now an FDA-approved treatment for adult patients with advanced renal cell carcinoma.
fdaapprovesbelzutifanadultpatients
https://catalogues.ema.europa.eu/node/3892/data-management
Non-interventional post-authorization study of belzutifan in adult patients with von Hippel-Lindau...
von hippel lindaunoninterventionalpostauthorization
https://www.vjoncology.com/video/eauayjsteps-real-world-belzutifan-efficacy-in-metastatic-clear-cell-renal-cell-carcinoma/
Real-world belzutifan efficacy in metastatic clear cell renal cell carcinoma - VJOncology
May 27, 2026 - Chris Labaki, MD, Dana-Farber Cancer Institute, Boston, MA, discusses a retrospective analysis from the International Metastatic Renal Cell Carcinoma Database...
real worldclear cellrenal carcinomabelzutifanefficacy